Cibus, Inc. (CBUS) Insider Trading Activity

NASDAQ$1.22+0.08 (7.02%)
Market Cap
$87.13M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
464 of 849
Rank in Industry
269 of 491

CBUS Insider Trading Activity

CBUS Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
–
Sells
$0
0
–

Related Transactions

About Cibus, Inc.

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, …

Insider Activity of Cibus, Inc.

Over the last 12 months, insiders at Cibus, Inc. have bought $0 and sold $0 worth of Cibus, Inc. stock.

On average, over the past 5 years, insiders at Cibus, Inc. have bought $0 and sold $154,120 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

List of Insider Buy and Sell Transactions, Cibus, Inc.

2025-06-13SaleSauer NoelSr VP, Research
4
<0.0001%
$1.49
$6
+1.34%
2025-02-25SalePrante Gerharddirector
1,150
0.0031%
$1.92
$2,208
-17.35%
2025-02-24SalePrante Gerharddirector
1,150
0.0034%
$2.07
$2,381
-15.63%
2025-02-21SalePrante Gerharddirector
1,150
0.0035%
$2.20
$2,530
-22.36%
2025-02-20SalePrante Gerharddirector
1,150
0.0034%
$2.35
$2,703
-25.00%
2025-02-19SalePrante Gerharddirector
1,150
0.0034%
$2.58
$2,967
-30.47%
2025-02-18SalePrante Gerharddirector
2,300
0.0068%
$2.52
$5,796
-37.93%
2025-02-14SalePrante Gerharddirector
1,150
0.0034%
$2.60
$2,990
-36.17%
2025-02-13SalePrante Gerharddirector
1,150
0.0034%
$2.53
$2,910
-37.45%
2025-02-12SalePrante Gerharddirector
1,150
0.0033%
$2.45
$2,818
-35.97%
2025-02-11SalePrante Gerharddirector
1,150
0.0034%
$2.48
$2,852
-35.71%
2025-02-10SalePrante Gerharddirector
1,150
0.0034%
$2.52
$2,898
-35.46%
2025-02-07SalePrante Gerharddirector
1,150
0.0034%
$2.50
$2,875
-35.66%
2025-02-06SalePrante Gerharddirector
1,150
0.0034%
$2.55
$2,933
-35.71%
2025-02-05SalePrante Gerharddirector
1,150
0.0034%
$2.52
$2,898
-35.71%
2025-02-04SalePrante Gerharddirector
1,150
0.0034%
$2.45
$2,818
-35.71%
2025-02-03SalePrante Gerharddirector
1,150
0.0033%
$2.41
$2,772
-34.41%
2025-01-31SalePrante Gerharddirector
1,150
0.0039%
$2.55
$2,933
-35.14%
2025-01-30SalePrante Gerharddirector
1,150
0.0034%
$2.46
$2,829
-36.47%
2025-01-29SalePrante Gerharddirector
1,150
0.0037%
$2.42
$2,783
-33.33%
Total: 63

CBUS Institutional Investors: Active Positions

Increased Positions21+28.77%995,662+8.68%
Decreased Positions29-39.73%470,481-4.1%
New Positions9New416,180New
Sold Out Positions15Sold Out326,926Sold Out
Total Postitions65-10.96%12M+4.58%

CBUS Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Fmr Llc$13,841.0013.89%7.36M+174,269+2.42%2025-09-30
Vantage Consulting Group Inc$2,151.002.16%1.14M00%2025-09-30
Vanguard Group Inc$1,809.001.82%962,370+106,222+12.41%2025-09-30
Blackrock, Inc.$538.000.54%286,027-195,207-40.56%2025-09-30
Geode Capital Management, Llc$494.000.5%262,713+4,973+1.93%2025-09-30
Certior Financial Group, Llc$347.000.35%184,786+11,230+6.47%2025-09-30
Gratia Capital, Llc$314.000.32%167,245-689,755-80.48%2025-09-30
Millennium Management Llc$277.000.28%147,491-36,033-19.63%2025-09-30
Granby Capital Management, Llc$188.000.19%100,00000%2025-09-30
State Street Corp$142.000.14%75,58900%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.